Literature DB >> 28966330

High Glucose Stimulates Mineralocorticoid Receptor Transcriptional Activity Through the Protein Kinase C β Signaling.

Takeshi Hayashi1,2, Hirotaka Shibata3, Isao Kurihara1, Kenichi Yokota1, Yuko Mitsuishi1, Kennosuke Ohashi2, Ayano Murai-Takeda1, Rie Jo1, Takako Ohyama1, Masaya Sakamoto2, Katsuyoshi Tojo2, Naoko Tajima2, Kazunori Utsunomiya2, Hiroshi Itoh1.   

Abstract

Activation of mineralocorticoid receptor (MR) is shown in resistant hypertension including diabetes mellitus. Although protein kinase C (PKC) signaling is involved in the pathogenesis of diabetic complications, an association between PKC and MR is not known. Activation of PKCα and PKCβ by TPA (12-O-Tetradecanoylphorbol 13-acetate) increased MR proteins and its transcriptional activities in HEK293-MR cells. In contrast, a high glucose condition resulted in PKCβ but not PKCα activation, which is associated with elevation of MR protein levels and MR transcriptional activities. Reduction of endogenous PKCβ by siRNA decreased those levels. Interestingly, high glucose did not affect MR mRNA levels, but rather decreased ubiquitination of MR proteins. In db/db mice kidneys, levels of phosphorylated PKCβ2, MR and Sgk-1 proteins were elevated, and the administration of PKC inhibitor reversed these changes compared to db/+ mice. These data suggest that high glucose stimulates PKCβ signaling, which leads to MR stabilization and its transcriptional activities.

Entities:  

Keywords:  Diabetes mellitus; Diabetic complication; Resistant hypertension

Mesh:

Substances:

Year:  2017        PMID: 28966330     DOI: 10.1536/ihj.16-649

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  6 in total

1.  Lysine-specific demethylase 1 as a corepressor of mineralocorticoid receptor.

Authors:  Nao Kohata; Isao Kurihara; Kenichi Yokota; Sakiko Kobayashi; Ayano Murai-Takeda; Yuko Mitsuishi; Toshifumi Nakamura; Mitsuha Morisaki; Takahide Kozuma; Takuto Torimitsu; Miki Kawai; Hiroshi Itoh
Journal:  Hypertens Res       Date:  2022-02-17       Impact factor: 3.872

2.  Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification.

Authors:  Rie Jo; Hirotaka Shibata; Isao Kurihara; Kenichi Yokota; Sakiko Kobayashi; Ayano Murai-Takeda; Yuko Mitsuishi; Takeshi Hayashi; Toshifumi Nakamura; Hiroshi Itoh
Journal:  Hypertens Res       Date:  2022-10-14       Impact factor: 5.528

3.  Primary Aldosteronism With Type 2 Diabetes Mellitus Requires More Antihypertensive Drugs for Blood Pressure Control: A Retrospective Observational Study.

Authors:  Kennosuke Ohashi; Takeshi Hayashi; Yui Watanabe; Koichiro Hara; Rikako Ukichi; Hiroshi Asano; Hirofumi Suzuki; Kenji Yamashiro; Katsuyoshi Tojo; Masaya Sakamoto; Kazunori Utsunomiya
Journal:  J Clin Med Res       Date:  2017-12-01

4.  Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study.

Authors:  Hiroshi Itoh; Sadayoshi Ito; Hiromi Rakugi; Yasuyuki Okuda; Satoshi Nishioka
Journal:  Hypertens Res       Date:  2019-06-25       Impact factor: 3.872

5.  Association between cortisol and left ventricular diastolic dysfunction in patients with diabetes mellitus.

Authors:  Rikako Sagara; Tomoaki Inoue; Noriyuki Sonoda; Chieko Yano; Misato Motoya; Hironobu Umakoshi; Ryuichi Sakamoto; Yoshihiro Ogawa
Journal:  J Diabetes Investig       Date:  2021-10-06       Impact factor: 4.232

Review 6.  "Greedy Organs Hypothesis" for sugar and salt in the pathophysiology of non-communicable diseases in relation to sodium-glucose co-transporters in the intestines and the kidney.

Authors:  Hiroshi Itoh; Masami Tanaka
Journal:  Metabol Open       Date:  2022-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.